Clinical Trials Browser

Completed × Small Cell Lung Carcinoma × 30 days × Clear all

NCT03881488 2026-04-17

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

Phase 1 Completed

DermatologicHead & NeckOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Melanoma, Mesothelioma, Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT07532057 2026-04-16

PR-LUNGCA-2019

Phase NA Completed

Lung Neoplasms, Neoplasms, Small Cell Lung Carcinoma

NCT04660097 2026-04-08

Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

Phase 2 Completed

Small Cell Lung Carcinoma

NCT04256421 2026-04-03

SKYSCRAPER-02

Phase 3 Completed

490 enrolled 33 charts

Small Cell Lung Carcinoma

NCT07489339 2026-03-30

SCLC-MDT

Phase NA Completed

Treatment Adherence and Compliance, Lung Neoplasms, Small Cell Lung Carcinoma